CH626535A5 - - Google Patents

Download PDF

Info

Publication number
CH626535A5
CH626535A5 CH504776A CH504776A CH626535A5 CH 626535 A5 CH626535 A5 CH 626535A5 CH 504776 A CH504776 A CH 504776A CH 504776 A CH504776 A CH 504776A CH 626535 A5 CH626535 A5 CH 626535A5
Authority
CH
Switzerland
Prior art keywords
ascorbic acid
reagent
acid
added
technetium
Prior art date
Application number
CH504776A
Other languages
German (de)
English (en)
Inventor
Harry S Winchell
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH626535A5 publication Critical patent/CH626535A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH504776A 1975-04-30 1976-04-22 CH626535A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/573,297 US4364920A (en) 1975-04-30 1975-04-30 Stable diagnostic reagents

Publications (1)

Publication Number Publication Date
CH626535A5 true CH626535A5 (ja) 1981-11-30

Family

ID=24291411

Family Applications (1)

Application Number Title Priority Date Filing Date
CH504776A CH626535A5 (ja) 1975-04-30 1976-04-22

Country Status (10)

Country Link
US (1) US4364920A (ja)
JP (1) JPS51148038A (ja)
BE (1) BE841261A (ja)
CA (1) CA1114291A (ja)
CH (1) CH626535A5 (ja)
DE (1) DE2619382A1 (ja)
DK (1) DK156540C (ja)
FR (1) FR2309215A1 (ja)
GB (1) GB1489330A (ja)
NL (1) NL189336C (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075314A (en) * 1976-04-29 1978-02-21 Mallinckrodt, Inc. Stannous pyrophosphate technetium-99m compositions
US4247534A (en) * 1978-07-31 1981-01-27 The Procter & Gamble Company Radiographic scanning agent
JPS55180577U (ja) * 1979-06-15 1980-12-25
JPS5750928A (en) * 1980-09-13 1982-03-25 Nippon Mejifuijitsukusu Kk Diagnostic agent for scanning bone
DE78642T1 (de) * 1981-10-30 1983-10-27 Amersham International Plc, Amersham, Buckinghamshire Radiopharmazeutische zubereitung auf grund von technetium-99m und reagenz zur herstellung derselben.
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4504462A (en) * 1982-06-10 1985-03-12 Mallinckrodt, Inc. Process for making a lyophilized product for use in skeletal imaging
US4504463A (en) * 1982-06-10 1985-03-12 Mallinckrodt, Inc. Process for making a lyophilized product for use in skeletal imaging
EP0096934B1 (en) * 1982-06-10 1986-11-26 Mallinckrodt, Inc. (a Delaware corporation) Radiographic imaging agents
ATE26071T1 (de) * 1982-06-10 1987-04-15 Mallinckrodt Inc Roentgen-sichtbarmachungsmittel.
US4440738A (en) * 1982-06-10 1984-04-03 Mallinckrodt, Inc. Stable radiographic imaging agents
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
EP0111414A3 (en) * 1982-12-08 1985-05-02 Mallinckrodt, Inc. (a Delaware corporation) Radiographic imaging agents
US4510125A (en) * 1982-12-08 1985-04-09 Mallinckrodt, Inc. Process for making lyophilized radiographic imaging kit
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
US4574079A (en) * 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
US4647445A (en) * 1984-03-28 1987-03-03 Massachusetts Institute Of Technology Radiolabelled lipoproteins and method for making same
JPS61103841A (ja) * 1984-10-26 1986-05-22 Nippon Mejifuijitsukusu Kk 放射性テクネチウム標識に供する安定な塩化第一スズ組成物
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
DE3621570A1 (de) * 1986-06-27 1988-01-07 Hoechst Ag Diagnostikum zur szintigraphischen darstellung von boesartigen tumoren
US4880615A (en) * 1988-11-25 1989-11-14 Merck & Co., Inc. Stabilized radiopharmaceutical compositions
EP0493526A4 (en) * 1989-09-22 1992-08-26 Neorx Corporation Stable therapeutic radionuclide compositions and methods for preparation thereof
US5306482A (en) * 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
WO1993002652A2 (en) * 1991-08-01 1993-02-18 Hybritech Incorporated Modified haptens useful as imaging and therapeutic agents
DE4332479A1 (de) * 1993-09-24 1995-03-30 Theodor Prasso Wasserkraftanlage zur Ausnutzung von Kleingefälle
US6027710A (en) * 1996-09-18 2000-02-22 Nihon Medi-Physiscs Co., Ltd. Radiation-protecting agent
US6231832B1 (en) 1998-03-23 2001-05-15 Brookhaven Science Associates Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use
WO1999051276A1 (en) * 1998-04-01 1999-10-14 Australian Nuclear Science & Technology Organisation Tin-free rhenium(v) complexes and methods for their preparation
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
US7556795B2 (en) * 2002-05-03 2009-07-07 Bracco Imaging S.P.A. Radiopharmaceutical formulations
EP1444990A1 (en) 2003-02-07 2004-08-11 Amersham plc Improved Radiometal Complex Compositions
CA2783275A1 (en) * 2003-07-24 2005-02-03 Bracco Imaging S.P.A. Stable radiopharmaceutical compositions and methods for their preparation
GB0718386D0 (en) * 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
US20100196272A1 (en) * 2009-01-30 2010-08-05 Neoprobe Corporation Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
FR2967671A1 (fr) * 2010-11-24 2012-05-25 Pf Medicament Complexe de technetium 99m en tant qu'outil de diagnostic in vivo des tumeurs cancereuses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2088149B1 (ja) * 1970-05-22 1974-05-24 Philips France
US3740418A (en) * 1970-07-01 1973-06-19 Squibb & Sons Inc Radioactive scanning preparation
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
US3902849A (en) * 1971-08-19 1975-09-02 Medi Physics Inc Radioisotope and radiopharmaceutical generators
CH566138A5 (en) * 1972-05-08 1975-09-15 Benes Ivan Diagnostic solns contg technetium 99 or indium 113 - from solns of low concn
HU167378B (ja) * 1972-05-08 1975-09-27
US3735001A (en) * 1972-05-24 1973-05-22 Atomic Energy Commission Technetium bone scanning medium
ZA743158B (en) * 1973-05-23 1975-05-28 Procter & Gamble Radiographic scanning

Also Published As

Publication number Publication date
DK156540B (da) 1989-09-11
US4364920A (en) 1982-12-21
DK156540C (da) 1990-02-05
JPS576409B2 (ja) 1982-02-04
FR2309215A1 (fr) 1976-11-26
DE2619382C2 (ja) 1988-09-01
NL189336B (nl) 1992-10-16
BE841261A (fr) 1976-10-29
NL7604475A (nl) 1976-11-02
GB1489330A (en) 1977-10-19
JPS51148038A (en) 1976-12-18
DE2619382A1 (de) 1976-11-11
FR2309215B1 (ja) 1979-09-28
DK156976A (da) 1976-10-31
NL189336C (nl) 1993-03-16
CA1114291A (en) 1981-12-15

Similar Documents

Publication Publication Date Title
CH626535A5 (ja)
DE2543350C2 (de) Präparate zur Herstellung von ↑9↑↑9↑↑m↑ Technetium-Radiodiagnostika
DE2538388A1 (de) Verfahren zur herstellung eines stabilen, nicht-radioaktiven traegermaterials und seine verwendung zur herstellung von tc-99m-markierten diagnosemitteln
EP0108253A1 (de) Technetium-99m-Tetraphosphonate zur szintigraphischen Darstellung RES-haltiger Organe und der Lymphgefässe und Verfahren zu deren Herstellung
DE2737932A1 (de) Mittel zur herstellung einer radiodiagnostischen loesung
DE2344802A1 (de) Technetium-99m-komplex und dessen verwendung zur radioaktiven untersuchung der skelettstruktur von saeugetieren
EP0313712B1 (de) Stabile radiodiagnostische Präparate und ihre Herstellung
DE69718406T2 (de) Strahlungsschutzmittel geignet zur Verwendung mit Radiopharmazeutika enthaltend reduzierbare aktive Inhaltsstoffe
DE2710728C2 (de) Reagens für die radiologische Abtastung von Organen, Verfahren zu seiner Herstellung und seine Verwendung
DE2423167A1 (de) Mercaptocarbonsaeure-radiopharmazeutika
DE2456693A1 (de) Verfahren zum stabilisieren von calcium-hydrogenphosphat-anhydrid gegen die umsetzung mit fluorionen
EP0141100B1 (de) N-(4-Aminobenzoyl)-aminodicarbonsäuren zur Stabilisierung von Technetium-99m-Präparaten, stabilisierte Injektionspräparate und Verfahren zu ihrer Herstellung
DE69414865T2 (de) Calcium-fluoride-komplex aufweisende mundspuelungen, zahnpasten, sowie kautabletten
DE2424496C3 (de) Zusammensetzung zur Herstellung eines Mittels zur scintigraphischen Knochenabtastung
EP0003041B1 (de) Technetium-99m-markiertes Diagnostikum zur Darstellung des retikuloendothelialen Systems (RES) und Verfahren zu seiner Herstellung
DE2838753A1 (de) Verfahren und ampulle zur herstellung von radiopharmazeutika
DE2602981A1 (de) Mittel zur dentalen prophylaxe
DE2755874A1 (de) Zinnhaltige markierungsbestecke, verfahren zu ihrer herstellung und praeparate zur skelettdarstellung
EP0335296B1 (de) Tc-99m-w-Alkylphosphinico-1-hydroxyalkan-1,1-diphosphonate enthaltende Präparate zur Knochenszintigraphie sowie Verfahren zur Herstellung dieser Präparate
DE2920909C2 (de) Dentalpräparat zur Verhütung und Hemmung der Zahnkaries
AT255655B (de) Verfahren zur Herstellung eines Zahnpflegemittels
DE2654298A1 (de) Stabiles, nicht-radioaktives traegermaterial, verfahren zu seiner herstellung und dieses traegermaterial enthaltende mittel
CH481649A (de) Zahnsteinlösendes Zahnputzmittel
DE2558572C3 (de) Röntgenkontrastmittel und bestimmte Inhaltsstoffe derselben
DE3323375A1 (de) N-(4-aminobenzoyl)-aminoessigsaeure zur stabilisierung von technetium-99m-praeparaten, stabilisierte injektionspraeparate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
PUE Assignment

Owner name: F. HOFFMANN-LA ROCHE AG

PUE Assignment

Owner name: AMERSHAM INTERNATIONAL PLC

PL Patent ceased